Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Banu Erturk"'
Autor:
Banu Erturk, Murat Tuncel, Diclehan Orhan, Ozlem Bozbeyi Turer, Omer Dizdar, Suleyman Nahit Sendur
Publikováno v:
JCEM Case Reports. 1
Introduction Therapeutic options for metastatic paraganglioma (PGL) are limited, especially in the presence of uncontrolled secondary hypertension (HTN). Early findings from Lutetium-177 (Lu-177) DOTATE show promise for efficacy, although data on HTN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6accb5e85c3519b8ef86b0e80eed2d36
https://doi.org/10.1210/jcemcr/luac014.003
https://doi.org/10.1210/jcemcr/luac014.003
Publikováno v:
JCEM Case Reports. 1
Introduction Bardet Biedl syndrome (BBS) is a rare hereditary disorder characterized by early-onset obesity, metabolic syndrome, type 2 diabetes, hypogonadism, polydactyly and renal failure. There is lack of data on the use of glucagon-like peptide-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9c56d8ee88623177470eed03c1a3a2d
https://doi.org/10.1210/jcemcr/luac014.036
https://doi.org/10.1210/jcemcr/luac014.036
Autor:
Selcuk Dagdelen, Banu Erturk
Publikováno v:
Journal of the Endocrine Society. 5:A957-A957
Objective: Incretins are expressed in thyroid tissue but without clearly-known clinical significance in human. The long-term effect of GLP-1 receptor activation on the thyroid is unknown. In the literature, liragludite-related thyroiditis has not bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68dddf93b58f6e512d8e90316dd6f666
https://doi.org/10.1210/jendso/bvab048.1956
https://doi.org/10.1210/jendso/bvab048.1956
Autor:
Nesrin Ugras, Saduman Balaban Adim, Ahmet Tarık Eminler, Talat Ayyildiz, Omer Yerci, Banu Erturk, Enver Dolar
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 16(1)
PubMed: 25640382 Background: Human adiponectin (ApN), a 30 kDa glycoprotein of 244-amino acids which is predominantly produced by adipocytes, exerts its effects via two receptors, namely adiponectin receptor-1 (adipo-R1) and adiponectin receptor-2 (a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d83906dfb821a8cca6927fa8d4eb61a3
https://pubmed.ncbi.nlm.nih.gov/25640382
https://pubmed.ncbi.nlm.nih.gov/25640382
